Soy Isoflavones Do Not Affect Bone Resorption in Postmenopausal Women: A Dose-Response Study Using a Novel Approach with 41Ca
Author(s) -
J. M. K. Cheong,
Berdine R. Martin,
George S. Jackson,
D. Elmore,
George P. McCabe,
Joseph R. Nolan,
Stephen Barnes,
Munro Peacock,
Connie M. Weaver
Publication year - 2006
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2006-0369
Subject(s) - isoflavones , bone resorption , osteocalcin , soy protein , bone remodeling , endocrinology , crossover study , medicine , urine , chemistry , resorption , osteoporosis , placebo , biochemistry , alkaline phosphatase , enzyme , alternative medicine , pathology
The purpose of this 3-way crossover study was to identify the effective dose of soy protein isolate enriched with isoflavones for suppressing bone resorption in postmenopausal women using a novel, rapid assessment of antibone resorbing treatments.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom